Supplementary table I- Efficacy and tolerance of dupilumab in obese patients with moderate-to-severe atopic dermatitis. Dupuis et al
收藏Mendeley Data2026-04-18 收录
官方服务：
资源简介：
Supplementary Table I: Adverse events during the follow-up period in patients treated with dupilumab.
创建时间：
2023-12-18
